Lima watak ceriakan warga Langkawi [ 50m ago ]

Otsuka Chemical acquires Cefixime business from Astellas Pharma

Last update: 07/06/2019

KUALA LUMPUR, June 7 (Bernama) -- Otsuka Chemical Co Ltd has succeeded part of the Cefixime business from Astellas Pharma Inc.

Under the agreement, Otsuka Chemical acquires Cefixime business to supply the Active Pharmaceutical Ingredient (API) to overseas licensees, along with assets such as contracts belonging to the licensing business and the trademark.

Otsuka Chemical’s entry into the API business results in strengthening the integrated antibiotic-related business from intermediates to API.

Cefixime was developed by Astellas Pharma, a third-generation cephalosporin with antibacterial activity against gram-positive and gram-negative bacteria, and it is extensively prescribed worldwide.

-- BERNAMA



       Previous Top Story